About
Pressroom
Resources
Get Updates
Issues
Access to Medicines
Funding the Fight
Health Justice
Transparency & Accountability
PEPFAR Watch
Blog
Our Impact
Take Action
Do something now
DONATE
Blog
Funding the Fight
Congress’s Spending Bill Does Not Meet the Moment
Access to Medicines
U.S. Torpedoes Extension of WTO TRIPS Decision to Include Tests and Treatments and Hides Behind the Façade of...
Health Justice
PEPFAR can’t keep burying its head in the sand when it comes to Key Populations
Funding the Fight
We’re turning up the heat on policymakers this World AIDS Day
Our Story
Q&A with Naike Ledan, Associate Director of International Policy & Advocacy
Access to Medicines
Switzerland and Mexico’s Communication to the TRIPS Council is Replete with Disinformation and Their Que...
Access to Medicines
Bad Faith from Big Pharma, Rich Countries and the WTO Poison WTO TRIPS Waiver Negotiations
Access to Medicines
Time to Walk Away from the WTO Proposed Text
Access to Medicines
The Quad TRIPS Waiver Text is not a Compromise; It is an Abomination
Access to Medicines
Moderna’s Global Public Health Strategy: Parsing the Hype and Shameful Access Gaps
Health Justice
Africa’s Key Populations Demand Bold Action, Not Empty Promises
Access to Medicines
Merck’s Molnupiravir – Overcoming impending barriers to affordable global access
Access to Medicines
Biggest Roadblock to Biden-Convened COVID-19 Summit’s Success: Fealty to Moderna and Pfizer
COVID-19
The Global Fund: A Foundation for Health Equity
Access to Medicines
Biden’s $2.7 billion investment in supply chains is a cynical boost to Big Pharma’s continued control over...
SEE MORE